Samuel Bobholz1, Allison Lowman2, Alexander Barrington3, Michael Brehler2, Sean McGarry1, Jennifer Connelly4, Elizabeth Cochran5, Anjishnu Banerjee6, and Peter LaViolette2,3
1Biophysics, Medical College of Wisconsin, Wauwatosa, WI, United States, 2Radiology, Medical College of Wisconsin, Wauwatosa, WI, United States, 3Biomedical Engineering, Medical College of Wisconsin, Wauwatosa, WI, United States, 4Neurology, Medical College of Wisconsin, Wauwatosa, WI, United States, 5Pathology, Medical College of Wisconsin, Wauwatosa, WI, United States, 6Biostatistics, Medical College of Wisconsin, Wauwatosa, WI, United States
Synopsis
This study
sought to assess the ability for voxel-wise MRI intensity values to distinguish
between co-registered pathological annotations of autopsy tissue samples from brain
cancer patients. Though single image and
pairwise image assessments did not reveal separable intensity distributions for
the pathological annotation classes, ensemble-based predictive modelling using
multiparametric MRI intensities proved able to predict pathological annotations
with modest accuracy. These results
suggest a complex relationship between MRI values and pathological features
that are most accurately assessed in terms of multiple MR imaging modalities.
Introduction
Clinical
MR imaging has been crucial for monitoring the treatment and progression of
glioblastoma (GBM) and other brain cancers.
T1-weighted imaging pre and post gadolinium contrast administration highlights
regions of blood brain barrier disruption caused by the brain tumor, whereas
FLAIR hyperintensities represent a combination of non-enhancing tumor and edemic
areas and regions. Diffusion imaging derived apparent diffusion coefficient
(ADC) has been shown to be inversely correlated with tumor cellularity [1–4].
However, without pathological validation in both tumor and non-tumor
tissue, these interpretations may be missing important information regarding
the location and content of the tumor, especially in the presence of treatment
effects. Furthermore, discerning between
regions of non-active tumor (i.e. necrotic regions, treatment-affected regions,
normal tissue) from regions of infiltrative tumor using MRI has yet to be
demonstrated.
This study
sought to further explore the separability of several pathologically relevant
categories in terms of MRI intensity values using autopsy tissue samples from
brain cancer patients. Specifically, we
tested the hypothesis that multiparametric MRI intensity values were able to
distinguish between pathologically annotated regions of the co-registered
post-mortem tissue.Methods
Nine
patients with a pathologically confirmed brain cancer were enrolled in this
study, whose clinical characteristics are summarized in Table 1. A schematic representation of the data
collection process is provided in Figure 2. Twenty tissue samples (representing the nine
patients) were collected at autopsy. For comparison, the final clinical imaging
session acquired prior to death was used. T1-weighted images pre (T1) and post
gadolinium contrast administration (T1C), fluid attenuated inversion recovery
(FLAIR) images, and ADC images calculated from diffusion weighted imaging were intensity
normalized and included in these analyses.
Autopsy samples were stained for hematoxylin and eosin (HE), digitized,
and annotated for areas of treatment effect (TE), hypercellularity (HC), and
hypercellular regions of pseudopalisading necrosis (PN), with unlabeled regions
abbreviated as UL. The histology images
and annotations were then co-registered to the MRI by using a custom in-house
software to perform nonlinear warping of the sample to the FLAIR image using
manually defined control points.Voxel-wise histological labels and MRI
intensity values for each image were then extracted over regions of interest
based on the quality assessments of the histology and MRI.
Single
image descriptions, pairwise descriptions, and a full data assessment were used
to delineate the relationship between the MRI intensity values and pathological
annotations at several parametric scales.
Intensity distributions for each label were plotted for each image in
order to assess the distinguishability of each annotation with regards to each
MRI. Pairwise confidence distributions
were assessed using the posterior probabilities from error-corrected output
coding (ECOC) models in order to observe the distinguishability of the annotations in
terms of each pair of MR images. Lastly,
a multi-class ensemble learner was fit using all four MRI values to model for
the annotation class, with accuracy assessed using a five-fold cross validation
split. Results
Single
image intensity distributions are presented in Figure 3. Despite slight differences in distributions,
single-image intensity values failed to offer annotation class separability in
this sample. Although pairwise intensity
distributions for each annotation seen in Figure 4 seem to reflect more
distinct patterns of annotation density than in the single image
characterization, these assessments still fail to distinctly separate the
annotation classes. Overall
classification error for the ensemble learner was 40%, with two of the four
classes (HC and PN) predicted accurately in a majority of cases. A confusion matrix for the ensemble
classifier is presented in Figure 5.Discussion
These
results address the complexity of the relationship between MRI intensity values
and pathologically defined regions.
Surprisingly, the ADC pairing provided the least distinct intensity
distribution for the HC class, suggesting
that areas of restricted diffusion may not be as selective for regions of
hypercellularity after the course of treatment and warranting future research. Furthermore, the pairwise assessment of class
separability in terms of the T1 and T1C [LP1] values did not reveal substantial
class distinctions, despite demonstrating increased separability compared to
the single image models in line with prior literature on T1 subtraction maps
and ADC-FLAIR mismatch [5,6].
The single and pairwise image findings suggest a need for caution in
interpretation of individual MR images with regards to pathological features of
brain cancer.
Despite the poor class separation of annotations
seen in single image intensity and in pairwise intensities, ensemble-based modeling
based on all four images provided meaningful separation between annotation
classes. This suggests that a
multiparametric relationship between MRI values and pathologically relevant
characteristics does exist, albeit a relationship dependent on complex modeling
for precise assessment. We were able to
achieve modest class distinguishability given our small sample size, and future
studies of larger data sets should be able to expound on this relationship and
potentially provide tools for clinical assessment using MR-predicted
pathological annotation labels.
[LP1]OUCH!
Suggest that treatment may change things and that future research is necessary.
Also cite my 2014 paper, which combined ADC and FLAIR to find hypercellularity.Conclusion
Though
pathological annotations do not demonstrate distinguishability in individual
and pairwise assessments of MRI intensity values, predictive models using
multiparametric imaging are able to predict post-mortem pathological annotations with
modest accuracy.Acknowledgements
We
would like to thank our patients for their participation in this study and our
funding sources: American Brain Tumor Association DG14004, R01CA218144,
R01CA218144-02S1, and R21CA23189201.References
1 Chen S-D, Hou P-F, Lou L, et al. The correlation between MR
diffusion-weighted imaging and pathological grades on glioma. Eur Rev Med Pharmacol Sci
2014;18:1904–9.
2 Durand-Munoz C,
Flores-Alvarez E, Moreno-Jimenez S, et al. Pre-operative apparent
diffusion coefficient values and tumour region volumes as prognostic biomarkers in glioblastoma:
correlation and progression-free survival analyses. Insights Imaging
2019;10:36. doi:10.1186/s13244-019-0724-8
3 Eidel O, Neumann J-O, Burth
S, et al. Automatic Analysis of Cellularity in Glioblastoma and
Correlation with ADC Using Trajectory
Analysis and Automatic Nuclei Counting. PLoS One 2016;11:e0160250.
doi:10.1371/journal.pone.0160250
4 Surov A, Meyer HJ, Wienke
A. Correlation between apparent diffusion coefficient (ADC) and cellularity is
different in several tumors: a meta-analysis. Oncotarget 2017;8:59492–9.
doi:10.18632/oncotarget.17752
5 LaViolette PS, Mickevicius
NJ, Cochran EJ, et al. Precise ex vivo histological validation of
heightened cellularity and diffusion-restricted necrosis in regions of dark
apparent diffusion coefficient in 7 cases of high-grade glioma. Neuro Oncol
2014;16:1599–606. doi:10.1093/neuonc/nou142
6 Ellingson BM, Aftab DT,
Schwab GM, et al. Volumetric response quantified using T1 subtraction
predicts long-term survival benefit from cabozantinib monotherapy in recurrent
glioblastoma. Neuro Oncol 2018;20:1411–8.
doi:10.1093/neuonc/noy054